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Abstract
Lipids are essential structural and functional components of cells. Little is known, however, about the evolution of lipid
composition in different tissues. Here, we report a large-scale analysis of the lipidome evolution in six tissues of 32 species
representing primates, rodents, and bats. While changes in genes’ sequence and expression accumulate proportionally to
the phylogenetic distances, <2% of the lipidome evolves this way. Yet, lipids constituting this 2% cluster in specific
functions shared among all tissues. Among species, human show the largest amount of species-specific lipidome differ-
ences. Many of the uniquely human lipidome features localize in the brain cortex and cluster in specific pathways
implicated in cognitive disorders.
Key words: humans, brain, lipidome, molecular evolution, mass spectrometry.
Introduction
Genome sequence and phenotype differences among species
are relatively well studied. This knowledge forms the founda-
tion for evolutionary models that explain observed genetic
and phenotypic divergence and help to identify genetic
regions or phenotypic traits influenced by a specific type of
evolutionary selection. Under most, though not all, current
models, the majority of genetic differences observed among
species are considered to be evolutionarily neutral, that is,
have no effect on the individuals’ survival and reproductive
abilities, while a few differences are adaptive, that is, increase
the individual’s fitness (Otto 2000; Eyre-Walker 2006; Hahn
2008; Orr 2009). Genetic changes with substantial deleterious
effects are removed by purifying selection and are not ob-
served in comparisons among species. Accordingly, some of
the main features of genetic evolution include: 1) an over-
whelming correlation between phylogenetic distances and
genetic distances; 2) reduced diversity (variation within spe-
cies) and divergence (differences between species) of func-
tional sequences compared with nonfunctional ones; and 3)
reduced diversity but the increased divergence of sequences
containing adaptive variants.
In contrast to genetic differences, most changes that occur
at the level of the phenotype affect individuals’ survival and
reproductive chances and only a few changes are neutral (Nei
2007; Steiner and Tuljapurkar 2012). While the genetic
information largely determines the phenotype, several inter-
mediate steps enable the transition of this information to the
phenotype level. These steps include changes in epigenetic
modification levels of DNA and histone proteins, RNA and
protein expression levels, as well as concentrations of small
molecules, metabolites, and lipids, that participate in all bio-
logical processes. Some of these steps, including RNA expres-
sion levels have been examined, resulting in evolutionary
models parallel to the one based on genetic data (Wray
et al. 2003; Jordan et al. 2005; Stern and Orgogozo 2008).
Yet, the driving forces determining evolutionary changes of
metabolite and lipid concentrations have not been explored.
In this study, we assess the evolution at another interme-
diate step connecting the genome with the phenotype—the
level of lipid concentration changes. Lipids represent the hy-
drophobic fraction of small biological molecules with a mo-
lecular weight <1500 Da, known as metabolites. Lipids are
essential components of cell plasma membranes, energy stor-
age blocks and signaling messengers in different cells and tis-
sues, especially those of the brain (Simons and Toomre 2000).
Their critical role in cell functioning is supported by their in-
volvement in metabolic and neurological disorders, such as
Alzheimer’s or Parkinson’s diseases, as well as in diabetes and
cancer (Han et al. 2002; Wenk 2005; Adibhatla et al. 2006; Ariga
et al. 2008; Colsch et al. 2008; Haughey et al. 2010; Lamari et al.
2013). Preliminary comparisons conducted in three to four
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mammalian species demonstrated the rapid evolution of lipid
concentration levels, in particular in the human lineage (Bozek
et al. 2015; Li et al. 2017). Nevertheless, the evolutionary pro-
cesses driving lipid concentration divergence among species,
including humans, remain unexplored. Here, we addressed
this question by analyzing the lipidome compositions of six
tissues in 32 mammalian species based on data collected using
liquid chromatography coupled with high-precision mass
spectrometry.
Results
Lipidome Data Description
We analyzed lipid concentrations in the liver (LV), muscle
(ML), kidney (KD), heart (HT), brain cortex (CX), and cere-
bellum (CB) using 669 samples obtained from 32 mammalian
species representing three phylogenetic clades: rodents, pri-
mates, and bats (Bozek et al. 2017) (fig. 1a and supplementary
table 1, Supplementary Material online). Our analysis was
based on the quantification of >18,000 (median¼ 18,708)
mass spectrometry features in each tissue corresponding to
hydrophobic compounds (lipids) detected in at least 50% of
the individuals of each species. Among these lipids, close to
7,000 (median¼ 6,994) were annotated in each tissue using
computational matching to the hydrophobic compound
database (Fahy et al. 2009) (fig. 1b; supplementary fig. 1 and
table 2, Supplementary Material online). A multidimensional
scaling analysis revealed that the samples segregated predom-
inantly according to organ origin (fig. 1c).
Lipidome Differences and Phylogenetic Distances
among Species
Most of the genome sequence differences and a substantial
proportion of gene expression differences among species tend
to scale linearly with phylogenetic distances. This indicates
that the majority of these changes might have no effect on
survival and reproductive abilities (Lanfear et al. 2010; Kuraku
et al. 2016). We used linear regression and Blomberg’s K (Ma
et al. 2015) approaches, analogous to the ones applied in the
genome sequence and gene expression analyses, to identify
lipids that change linearly with phylogenetic distances
between species (phylogeny-dependent lipids). Surprisingly,
on an average, only 2% of detected lipids showed this
type of concentration differences (R2: median¼ 1.9%,
maximum¼ 9.2% in CB; Blomberg’s K: median¼ 2.1%,
maximum¼ 9.1% in CB; fig. 2a and supplementary figs.
2–9, Supplementary Material online). Notably, the ob-
served proportions of phylogeny-dependent lipids were
still significantly greater than expected by chance in all six
tissues (permutations, P< 0.001). The result was not
caused by the selection of species used in the study: a
parallel analysis of the transcriptome and lipidome diver-
gence in a subset of three tissues of eight species dem-
onstrated that 30–37% of detected protein-coding
transcripts showed phylogeny-dependent expression.
For the lipids, however, the median proportion of
phylogeny-dependent differences remained low (3.3%)
(fig. 2b and supplementary fig. 10, Supplementary
Material online).
FIG. 1. Data overview. (a) Phylogenetic tree of 32 mammalian species used in this study. The colors indicate three main represented clades: rodents
(blue), primates (red), and bats (green). (b) Numbers of lipids detected in each tissue. Gray bars represent annotated lipids. Here and later the
tissues are labeled by a two-letter code: CB, cerebellum; CX, cortex; HT, heart; KD, kidney; LV, liver; ML, muscle. (c) The relationship among samples
are based on concentrations of 1,231 annotated lipids plotted in two dimensions using a multidimensional scaling algorithm. Symbols represent
tissues, colors represent clades, and points represent individual samples.
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On an average, phylogeny-dependent lipids showed fewer
lipid concentration differences among species than the
remaining lipids in all six tissues combined (two-sided
t-test, n¼ 66,176, P< 0.0001, fig. 2c), as well as in each tissue
separately, except the cerebellum (supplementary fig. 11,
Supplementary Material online). Furthermore, phylogeny-
dependent lipids showed reduced intraspecies variation
(two-sided t-test, n¼ 3,916, P< 0.0001, fig. 2d and supple-
mentary fig. 12, Supplementary Material online). These results
were not caused by the difference in concentration levels
between phylogeny-dependent and the remaining lipids or
by outlier effects (see “Materials and Methods” and supple-
mentary fig. 13, Supplementary Material online).
Remarkably, despite the relatively low numbers of
phylogeny-dependent lipids annotated in each tissue
(Nmin¼71, Nmedian¼148), they showed unusually strong en-
richment in the same lipid class, fatty amides and its subclass
N-acyl amides, in all six tissues (hypergeometric test,
n¼ 3,134, 3,979, 5,858, 5,977, 5,685, and 3,384 in CX, CB,
HT, KD, LV, and ML, respectively, FDR< 0.01 in each tissue)
(fig. 2e). Several other lipid classes, including phosphosphingo-
lipids, and fatty acyl glycosides, were also enriched in phylog-
eny dependent lipids in one or several tissues (supplementary
table 3, Supplementary Material online).
Species-Specific Lipidome Differences
To further assess the evolutionary dynamics of lipid concen-
tration levels, we identified species-specific differences defined
as significant lipid concentration differences between a given
species and the others (fig. 3a). The analysis was based on lipid
concentration measurements from three individuals per spe-
cies, sampled randomly among all measured species’ individ-
uals. Among all 104 tissue and lineage combinations
represented by at least three biological replicates, only three
FIG. 2. Relationship between lipid concentrations and phylogenetic distances. (a) Percentages of lipids with concentration differences among
species scaling with phylogenetic distances (phylogeny-dependent lipids) in each of six tissues. Stars indicate the significance of the difference
between observed number distributions and random expectation (permutations of species labels, P< 0.001). (b) Percentages of phylogenetic
genes (violet) and lipids (green) defined based on the same criteria in three tissues in a matching subset of eight species. The expression data was
taken from Fushan et al. (2015). (c) Distribution of concentration differences measured in all pairwise comparisons between species for phylogeny-
dependent lipids (blue) and the remaining lipids (light gray). Stars indicate the significance of the difference between the two distributions (two-
sided t-test P< 0.0001, n¼ 66,176). (d) Distribution of concentration differences among individuals within species for phylogeny-dependent lipids
(blue) and the remaining lipids (light gray). Stars indicate the significance of the difference between the two distributions (two-sided t-test
P< 0.0001, n¼ 3,916). (e) Enrichment of phylogeny-dependent lipids in specific lipid classes and subclasses. Colors indicate BH-corrected
enrichment P values.
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combinations showed significantly more species-specific lipid
concentration differences than expected by chance (permu-
tations, P< 0.05 at Wilcoxon test P< 0.01 cutoff) and five
showed a marginally significant trend (permutations, P< 0.1
at Wilcoxon test P< 0.01 cutoff) (fig. 3b). Of these eight, three
were located in the human lineage: two significant ones in the
brain cortex and kidney and one marginally significant one in
the heart. The use of an alternative approach, the
Ornstein–Uhlenbeck (OU) model, confirmed three out of
three combinations located in the human lineage (permuta-
tions, P< 0.05 at the OU model P< 0.01 threshold) (supple-
mentary fig. 14, Supplementary Material online). Additionally,
the human kidney showed a marginally significant excess of
lineage-specific differences (permutations, P< 0.1 at the OU
model P< 0.01 threshold). By contrast, an excess of species-
specific lipidome differences in the other lineages was not
FIG. 3. Species-specific lipid concentration differences. (a) Numbers of lipids showing significant species-specific concentration differences. The
distributions show the numbers of such lipids in each of 23 lineages represented by at least three biological replicates in a given tissue. (b) Numbers
of lipids showing significant species-specific concentration differences in each of 104 tissue and lineage combinations (normalized by the
phylogenetic distances). Error bars show variations of estimates calculated by way of the random sampling of three individuals per species.
Stars and bar colors indicate the significance of the difference between observed number distributions and random expectation (permutations, **
and red—P< 0.05, * and pink—P< 0.1). Green circles indicate the significance of the difference between observed number distributions and
random expectation according to the OU model (permutations, oo—P< 0.05, o—P< 0.1). The rightmost column shows the cumulative lineage
effect calculated as an average -log10 P value of the difference between observed and chance numbers of species-specific lipids across tissues. (c)
Lipid concentration differences between humans and the other three species (chimpanzee, macaque, and mouse) calculated as log2-transformed
fold changes of the average values for 183 lipids showing a significant human-specific concentration difference in our data (Data Set 1) and
detected in the published data set (Data Set 2) (Bozek et al. 2015). Colors indicate signs of log2-transformed fold changes in both data sets. The
ellipse shows a 90% confidence interval. (d) An example of the concentrations in the kidney of one lipid (monogalactosyldiacylglycerol,
LMGL05010014) shown in the panel (c). (e) Enrichment of lipids with human-specific concentration differences in specific lipid classes and
subclasses. Colors indicate BH-corrected enrichment P values.
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confirmed by the OU model, except the mouse cerebellum
(fig. 3b). This result indicates the outstanding character of the
lipidome evolution in the human lineage, while a robust de-
tection of more subtle species-specific signals in the other
lineages might require greater sample sizes. Consequently,
the human evolutionary lineage stood out as having the
greatest average lineage-specific lipid concentration diver-
gence compared with the other examined mammalian line-
ages (fig. 3b).
The excess of lipid concentration changes in the human
linage was not caused by differences in the postmortem delay
among samples, as estimated based on postmortem delay
effects identified in Bozek et al. (2015). This excess was not
caused by environmental effects either, as human-specific
lipid concentration changes were enriched in the brain, yet
most lipids composing brain tissue are synthesized in the
brain and, therefore, are shielded from environmental and
dietary changes by the blood–brain barrier (Sherman and
Brophy 2005; Piomelli et al. 2007). Additionally, environmen-
tal exposure experiments (stress, exercise, and diet factors)
conducted in macaques showed that each of the environ-
mental perturbations induced substantially fewer lipid con-
centration changes compared with the lipidome differences
observed between chimpanzees and humans (Bozek et al.
2015). Consistently, the largest effect of environmental factors
was observed in the kidney, and the smallest—in the brain
prefrontal cortex (Bozek et al. 2015). Moreover, human-
specific differences detected in this study were in agreement
with the differences calculated using a published lipidome
data set (Bozek et al. 2015) (fig. 3c and d, Fisher’s test,
OR¼ 6.5, P< 0.0001).
Lipids showing human-specific concentration changes
(HS-lipids) in the brain cortex were clustered in two specific
lipid classes, glycerophosphoethanolamines and diradylglycer-
ols and their three subclasses (fig. 3e). Similarly, enzymes
linked to HS-lipids demonstrated an excess of human-
specific expression changes in the cortex (two-sided t-test,
n¼ 257, P¼ 0.0004) (fig. 4a), and were significantly overrep-
resented in 11 KEGG pathways (the Kyoto Encyclopedia of
Genes and Genomes; Kanehisa et al. 2017) (hypergeometric
test, n¼ 511, BH-corrected P< 0.0001, fig. 4b and supple-
mentary table 4, Supplementary Material online). Of them,
three interlinked pathways, glycerophospholipid metabolism,
glycerolipid metabolism, and linoleic acid metabolism path-
ways, showed the strongest overrepresentation of both
protein-coding genes and lipids showing human-specific ex-
pression and concentration levels (fig. 4c). Notably, enzymes
linked to the brain-specific lipids showed a conservation sig-
nature compatible with increased purifying selection pressure
(fig. 5a and b), suggesting their functional importance, despite
a reduction of the expression level in brain (Wilcoxon test,
n¼ 131, P< 0.0001, fig. 5c).
Discussion
Recent technical advances in measuring lipidome composi-
tion in multiple species allow us to assess the evolution at a
new level of molecular phenotype: the level of lipid
concentrations. Our analysis based on lipidome measure-
ments conducted in six tissues of 32 mammalian species
resulted in several remarkable observations. First, in contrast
to genetic and gene expression data, where 84.8% and 25.6%
of differences among species were proportional to phyloge-
netic distances, only 1.9% of all lipids’ concentrations scaled
with the phylogeny (fig. 6a). Moreover, unlike genetic and
gene expression changes, lipid concentration changes that
followed the phylogeny did not show characteristic features
of a neutral evolutionary model. Specifically, while much
more abundant genetic and gene expression changes did
not cluster in any functional categories (hypergeometric
test, n¼ 5,206, 5,219, 5,120, 5,206, and 5,062 in CX, CB, HT,
KD, and LV, respectively, BH-corrected P> 0.1, supplemen-
tary table 5, Supplementary Material online), the few lipids
that followed the phylogeny were grouped in the same par-
ticular lipid class, fatty amides, in all six tissues. These lipids
showed smaller amplitude of concentration differences
among species and varied less within species than the rest
of the lipidome. Taken together these two observations, the
remarkable agreement between tissues, which otherwise have
very different lipidome compositions, and reduced concen-
tration variation, suggests the importance of fatty amides in
as yet unexplained functions related to an evolutionary
“clock-like” lipidome divergence in all tissues. The review of
the known features of fatty amides revealed that they are
indeed found in all tissues of mammal species (Zoerner
et al. 2011). However, the evolution of fatty amides and, in
particular, of their most abundant subclass endocannabinoids,
represented by 15% of all fatty amides detected in six tissues,
has been studied at the genetic level only (McPartland et al.
2006; Elphick 2012). Like the pharmacologically active com-
pounds in marijuana or cannabis, endocannabinoids exert
their effects by binding to and activating specific cannabinoid
receptors CB1 and CB2. The endocannabinoids produce neu-
robehavioral effects and have key neurotransmitter roles in
the central nervous system, especially in the perception of
pain, stress, and anxiety, in energy balance and in appetite
control (Piomelli 2003). Moreover, endocannabinoids have
anti-inflammatory and anticancer properties (De Petrocellis
et al. 2000).
We further assessed the possible relationship between the
lipidome and species’ phenotypes by identifying lipid concen-
tration changes unique to each species. Even though the
number of individuals per species was limited, we were able
to examine 23 lineages represented by at least three biological
replicates per tissue, and detected a significant excess of lip-
idome changes in three lineages—the human, mouse, and
chinchilla ones—as well as a marginally significant trend in
the two bat lineages. Notably, the human lineage stood out
among the rest by showing the greatest cumulative species-
specific divergence. Due to the small numbers of individuals
examined in our study, it is likely that many species-specific
lipid concentration changes remained undetected. Still, it is
noteworthy that among 23 lineages used in the analysis, the
human one showed the most pronounced excess of lipid
concentration changes. Furthermore, of all species, only
humans showed a significant excess of lipid concentration
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changes in the brain cortex. This result agrees well with obser-
vations of accelerated lipidome evolution in the human brain
(Bozek et al. 2015; Li et al. 2017).
Human-specific lipidome changes were most pronounced
in the brain cortex and kidney, but only cortical changes
clustered in distinct functional pathways, particularly in glyc-
erolipid, glycerophospholipid, and linoleic acid metabolism.
These pathways were implicated in a number of neurodegen-
erative disorders such as Alzheimer’s disease (Snowden et al.
2017), Parkinson’s disease (Cheng et al. 2011), and neurode-
generation with brain iron accumulation (Morgan et al. 2006),
as well as other nervous system disorders: hereditary spastic
paraplegia, congenital myasthenic syndrome, Fabry disease,
pyridoxine-dependent epilepsy, and Sjo¨gren–Larsson syn-
drome (Kanehisa et al. 2017).
To conclude, our observations indicate that lipid concen-
trations evolve differently compared with genome sequences
and gene expression levels. We speculate that lipid evolution
represents phenotypic differences between species more
closely than genomic and gene expression differences do,
with a greater proportion of differences accumulating among
species representing functional changes shared among tissues
(fig. 6b), while tissue-specific lipidome differences might rep-
resent species-specific adaptations.
Materials and Methods
Source of Samples
Human samples were obtained from the NICHD Brain and
Tissue Bank for Developmental Disorders at the University of
FIG. 4. Characterization of lipids showing human-specific concentration levels (HS-lipids) in cortex. (a) Distribution showing numbers of protein-
coding genes with human-specific expression in cortex linked to HS-lipids (violet) and control lipids (gray). Stars indicate the significance of the
difference between the two distributions (two-tailed t-test P< 0.001, n¼ 257). (b) Enrichment of protein-coding genes linked to HS-lipids in KEGG
pathways. Symbols represent pathways. The numbers next to the symbols and the legend above the panel show the top three enriched pathways.
(c) The simplified schematic representation of the top three enriched KEGG pathways showing HS-lipids and their linked genes. The background
colors indicate the pathways, as in panel (b) legend.
Khrameeva et al. . doi:10.1093/molbev/msy097 MBE
1952
Maryland, the Netherlands Brain Bank, and the Chinese Brain
BankCenter(CBBC,http://cbbc.scuec.edu.cn,Wuhan,China). In
accordance with the protocols of these institutions, specific per-
missionforbrainautopsiesandtheuseofbraintissueforresearch
purposes was given by the donors or their relatives. The use of
human autopsy tissue is considered nonhuman subject research
andisIRBexemptunderNIHguidelines.Allsubjectsweredefined
as healthy with respect to the sampled tissue by forensic pathol-
ogists at the corresponding tissue bank. All subjects suffered
sudden death with no prolonged agony state.
Primate samples were obtained from Simian Laboratory
Europe (SILABE) in Strasburg, research unit CNRS-MNHM
717 in Brunoy, France, the German Primate Center (DPZ)
in Goettingen, the Max Planck Institute for Anthropology
in Leipzig, Germany, the Suzhou Experimental Animal
Center in China, the Anthropological Institute and
Museum of the University of Zu¨rich-Irchel, Switzerland, and
the Biomedical Primate Research Centre in the Netherlands.
All nonhuman primates used in this study suffered sudden
deaths for reasons other than their participation in this study
and without any relation to the tissue used.
Rodent samples were obtained from the University of
Rochester Biology Department, MDC Berlin, Department of
Zoology and Entomology, University of Pretoria, and the an-
imal center at the Shanghai Institute for Biological Sciences.
All mice were from the C57/BL6 strain with no genetic mod-
ifications. Bat samples were obtained from Kunming Institute
of Zoology of the Chinese Academy of Sciences. The use and
care of the animals in this research was reviewed and ap-
proved by the Biological Research Ethics Committee,
Shanghai Institutes for Biological Sciences, Chinese
Academy of Sciences. All samples were lawfully acquired
and their retention and use were in every case in compliance
with national and local laws and regulations. Additionally, all
nonhuman samples acquisition, retention and use were in
every case in accordance with the Institute for Laboratory
Animal Research (ILAR) Guide for the Care and Use of
Laboratory Animals.
FIG. 5. Evolution of two mutually exclusive groups of lipid-metabolizing enzymes: 1) enzymes linked to brain-specific lipids and 2) enzymes linked
to nonbrain-specific lipids. Brain-specific lipids were defined as the 20% of lipids with the highest log2-transformed fold-change of the average
concentration difference between brain and the other tissues. Nonbrain-specific lipids were defined as 20% of lipids with the lowest log2-
transformed fold-change in the same comparison. (a) Dn and Ds values of the two groups of lipid-metabolizing enzymes. (b) Dn/Ds ratios of
the two groups of lipid-metabolizing enzymes. (c) Average expression levels of the two groups of lipid-metabolizing enzymes. The colors indicate
the enzymes linked to brain-specific lipids (red) and the enzymes linked to nonbrain-specific lipids (blue).
FIG. 6. Evolution at lipidome, transcriptome and genome levels. (a) Percentages of lipids, protein-coding transcripts and genes with differences
among species accumulating proportionally to phylogenetic distances. (b) Schematic representation of the suggested lipidome evolution prop-
erties in comparison to the other levels of molecular and organismal phenotype. Left: relative proportions of neutral and functional differences
among species. Right: proportion of evolutionary differences shared among tissues. The vertical axis shows the relevant levels of organismal
organization. The inversion of this proportion between the transcriptome and lipidome levels reflects the notion that ubiquitously present
transcriptome differences are mainly neutral and lipidome ones are mainly functional.
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Normalization of Concentrations
To limit potential technical artifacts, mass spectrometric
peaks that had zero values in>50% of individuals, were re-
moved. All peak concentration values were then normalized
by the internal standard (IS) concentration levels and log2
transformed. Before the log2 transformation, we added 1 to
the concentration values in order to avoid infinite values.
Missing concentration values were ignored in further analyses.
Normalized concentrations were transformed into Z-scores
for each peak.
Peak Annotation
Peaks were matched to the LIPID MAPS database as described
in Fahy et al. (2009). Peaks showing a correlation>0.7 and a
difference in RT of<0.05 that matched the same hydropho-
bic compound in the database search were merged together.
This procedure resulted in the merging of 427–880 peaks in
different tissues into composite peaks of size of up to six. As a
result, the data sets contained between 5,313 and 13,067
compounds in different tissues and ionization modes and
between 13,089 (cerebellum) and 20,669 (heart) compounds
in both ionization modes together (fig. 1b).
We used LIPID MAPS (Fahy et al. 2009), HMDB (Wishart
et al. 2009), and KEGG (Kanehisa et al. 2017) database
annotations to assign each identified compound to its lipid
class, subclass, and pathway. Unannotated peaks were ex-
cluded from further analysis (supplementary table 2,
Supplementary Material online). About 1,231 peaks were
detected and annotated across all six tissues, and were fur-
ther used to estimate the relationship among samples with
a multidimensional scaling algorithm, after quantile nor-
malization of concentration values (fig. 1c).
We tested the overrepresentation of lipid classes, sub-
classes, and pathways in a given group of peaks (lipids) using
a hypergeometric test corrected for multiple testing by the
Benjamini and Hochberg method (figs. 2e and 3e).
Identification of Lipids and Genes That Follow
Phylogeny
To estimate lipid concentration changes during evolution, we
fitted a linear model for each lipid using concentration differ-
ences between any two samples as dependent variables and
phylogenetic distances for the same samples as independent
variables. Phylogenetic distances were obtained from the phy-
logenetic tree http://www.timetree.org/ (Kumar et al. 2017).
Based on the linear models, for each lipid we estimated a
coefficient of determination (R2), which in this case is a mea-
sure of the relationship between concentration differences
and phylogenetic distances (supplementary fig. 2,
Supplementary Material online). Additionally, we quantified
the phylogenetic signal in lipid evolution using Blomberg’s K
as described in Ma et al. (2015). As both approaches yielded
similar results (supplementary figs. 3 and 4, Supplementary
Material online), we defined phylogeny-dependent lipids as
the ones with R20.1 (fig. 2a). To determine the validity of
this cutoff, we calculated Spearman correlations between
concentration differences and phylogenetic distances. All lip-
ids with concentration differences between species following
phylogenetic distances demonstrated positive correlation
coefficients. Moreover, we obtained qualitatively similar
results at a different R2 cutoff (R20.2, supplementary fig. 5,
Supplementary Material online).
To construct the background distribution of R2 values, we
performed 1,000 permutations of species labels across sam-
ples within clades, and for all samples as well, and repeated R2
calculation procedure described above for each permutation
(fig. 2a). The same procedure was carried out in Blomberg’s K
distribution analysis (supplementary fig. 4, Supplementary
Material online).
Additionally, we performed permutations for individual
lipids. Specifically, in each tissue, we performed 1,000 permu-
tations of species labels, while preserving data structure, that
is, all individuals representing one species were switched to a
new species label together. We then defined the permuta-
tion P value as the proportion of permutations where the
coefficient of determination (R2) or Blomberg’s K was higher
than or equal to the original one (supplementary figs. 6
and 7, Supplementary Material online). All lipids defined
as phylogeny-dependent by either R2 or Blomberg’s K
passed the permutation P value cutoff of 0.05, and >93%
passed the permutation P value cutoff of 0.01 (supplementary
figs. 8 and 9, Supplementary Material online).
The exact same analysis was performed for the gene ex-
pression data set GSE43013 (Fushan et al. 2015). For the data
set preprocessing, genome annotations were obtained from
Ensembl, release 90. Paired-end reads were downloaded from
SRA and mapped using STAR v2.5.3a with default settings.
Average gene expression levels were calculated as FPKM using
RSEM v.1.2.31. Orthologs were obtained from Ensembl bio-
mart, release 90. To eliminate unambiguity, genes that had
more than one ortholog in the same species were removed.
Further, FPKM values were log2 transformed, and quantile
normalization was applied. Genes that had missing values
in50% of individuals were removed. To compare percen-
tages of phylogeny-dependent protein-coding genes and lip-
ids, we analyzed transcriptome and lipidome data in a
matching subset of three tissues of eight species: H. sapiens,
P. troglodytes, M. mulatta, M. musculus, R. norvegicus, M. aur-
atus, C. porcellus, H. glaber (fig. 2b).
Additionally, we repeated the same analysis for the gene
expression data set GSE30352 (Brawand et al. 2011). To com-
pare percentages of phylogeny-dependent protein-coding
genes and lipids, we analyzed transcriptome and lipidome
data in a matching subset of four tissues of eight species:
P. troglodytes, M. mulatta, H. sapiens, C. capucinus, C. jacchus,
M. musculus, H. glaber, and H. armiger for lipidome data and
P. troglodytes, M. mulatta, H. sapiens, M. musculus, G. gorilla,
P. pygmaeus, M. domestica, and O. anatinus for transcriptome
data (supplementary fig. 10, Supplementary Material online).
Identification of Protein Coding Sequences That
Follow Phylogeny
Orthologous coding sequences for mammal species were
obtained from the OrthoMaM database (v9) (Douzery et al.
2014). We estimated pairwise distances between two orthol-
ogous sequences using the Jenson–Shannon divergence
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measure implemented in Spaced words software (Horwege
et al. 2014). To fit linear models, the obtained Jenson–
Shannon divergences were used as dependent variables,
and phylogenetic distances between the same species were
used as independent variables. Based on the linear models, for
each protein sequence we estimated a coefficient of determi-
nation (R2). Further steps were performed exactly as for lipids
(see above, fig. 6a).
Analysis of Lipid Concentration Differences within
and between Species
To construct the control lipid group, we selected a subset of
remaining lipids so as to ensure its size and concentration
distribution were the same as those of phylogeny-dependent
lipids.
To estimate intraspecies differences of lipid concentrations
among individuals, we calculated pairwise Spearman correla-
tions of concentrations between samples derived from the
same species (fig. 2d and supplementary fig. 12,
Supplementary Material online). To estimate interspecies dif-
ferences of lipid concentrations among individuals, we calcu-
lated pairwise Spearman correlations of concentrations
between samples derived from different species (fig. 2c and
supplementary fig. 11, Supplementary Material online). Since
evolutionarily distant species might yield lower interspecies
Spearman’s correlation coefficients than the closely related
ones, we additionally normalized the obtained values by the
average phylogenetic distances between this species and the
rest. For all lipids, we defined intraspecies concentration dif-
ferences as 1 minus the intraspecies Spearman correlation
and interspecies concentration differences as 1 minus the
interspecies Spearman correlation (supplementary fig. 15,
Supplementary Material online). All calculations were per-
formed for each tissue separately.
To confirm our observations, we repeated the analysis for
phylogeny-dependent lipids defined using Blomberg’s K as
described in Ma et al. (2015) at K 1.2 cutoff (supplementary
fig. 16, Supplementary Material online).
Identification of Species-Specific Lipids
For each lipid, we compared concentrations in one species
against all other species using the Wilcoxon test. If the
Wilcoxon test P value was lower than the chosen cutoff
(0.01), the lipid was defined as species-specific (fig. 3a). To
balance the number of samples per species, we randomly
selected three samples in each species, repeated the proce-
dure 100 times, and calculated the sum number of species-
specific lipids among 100 iterations for each species. Because
the analysis was applied to each species and each tissue sep-
arately, it was limited to 23 out of 32 lineages containing at
least three biological replicates in a given tissue. Since evolu-
tionarily distant species might yield higher numbers of
species-specific lipids than the closely related ones, we nor-
malized the obtained numbers of species-specific lipids by the
average phylogenetic distances between this species and the
rest. To test whether the observed number of species-specific
lipids was higher than expected by chance, we permuted
species labels between samples 100 times, each time
calculating the number of species-specific lipids as described
earlier. For each species, we then calculated the permutation
P value as the proportion of permutations resulting in an
equal or greater number of significant lipids at the chosen
nominal significance cutoff (0.01, fig. 3b). The analysis was
performed for lipids measured in the negative ionization
mode only, which included the majority of detected lipids.
To confirm our observations with an alternative approach,
we estimated the number of species-specific lipids using the
Ornstein–Uhlenbeck (OU) model, as implemented in R pack-
age ouch (Butler and King 2004). To find whether changes in
optimal lipid concentration have occurred at a particular
branch of the phylogenetic tree, we tested the null hypothesis
that all branches share the same optimum parameter against
the alternative hypothesis that there is a distinct optimum at
a different phylogenetic branch corresponding to a particular
species. For each lipid, we built an S0 model (one global op-
timum across all species) and S1, S2, . . ., Sx models (different
optimums for particular species x). Based on these models, we
used the likelihood ratio test between a species-specific selec-
tive regime Sx model and the S0 model. The likelihood ratio
between Sx and S0 had an asymptotic v2 distribution (with
one degree of freedom) from which a P value could be cal-
culated. If the P value was lower than the chosen cutoff (0.01),
the lipid was defined as species-specific (supplementary fig.
14, Supplementary Material online). To balance the number
of samples per species, we randomly selected three samples in
each species, repeated the procedure 100 times, and calcu-
lated the sum number of species-specific lipids among 100
iterations for each species. To test whether the observed
number of species-specific lipids was higher than expected
by chance, we performed permutations exactly as described
earlier for species-specific lipids defined using the Wilcoxon
test.
Comparison with Published Data Set
We defined lipids with human-specific concentration changes
as lipids demonstrating Wilcoxon test P values (for human-
vs.-other-species comparisons) of<0.05 in 95% of bootstraps
in one tissue. Bootstraps were performed via the random
selection of three individuals per species, repeated 100 times.
Lipids with missing values in50% of permutations were
removed. To compare the remaining lipids with a published
data set (Bozek et al. 2015) we selected lipids with a common
annotation in both data sets. In cases when multiple
LIPIDMAPS IDs were assigned to each lipid, we selected lipids
that shared the greatest number of LIPIDMAPS IDs in the two
data sets. We plotted concentration distributions for these
lipids (fig. 3d). Additionally, we calculated log2-fold changes
between human lipid concentrations and average lipid con-
centrations of chimpanzees, macaques, and mice (fig. 3c). To
check if log2-fold change values were in agreement between
data sets, we performed the Fisher’s test.
Human-Specific Gene Expression Changes
We defined lipids with human-specific concentration changes
as lipids demonstrating Wilcoxon test P values (for human-
vs.-other-species comparisons) of<0.01 in 75% of bootstraps
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(three random individuals per species) in one tissue. We se-
lected enzymes directly linked to the lipids according to the
KEGG database (Kanehisa et al. 2017), and defined protein-
coding genes with human-specific expression as those show-
ing Wilcoxon test P values of <0.05 for humans vs. other
primate comparisons in one tissue, according to gene expres-
sion values in the public data set GSE30352 (Brawand et al.
2011) (fig. 4a).
We tested the overrepresentation of KEGG pathways in
each gene group using a hypergeometric test corrected for
multiple testing by the Benjamini and Hochberg method
(fig. 4b and c).
Evolution of Lipid-Metabolic Enzymes
We defined brain-specific lipids as 20% of lipids with the
highest log2-fold changes of average concentrations in brain
tissues (CB and CX) compared with the remaining tissues
(n¼ 1504), and nonbrain-specific lipids as 20% of lipids
with the lowest log2-fold changes (n¼ 1504). Then we se-
lected enzymes directly linked to the lipids according to the
KEGG database (Kanehisa et al. 2017), and divided them into
three groups: 1) enzymes linked to the brain-specific lipids but
not to the nonbrain-specific lipids (n¼ 65); 2) enzymes linked
to the nonbrain-specific lipids but not to the brain-specific
lipids (n¼ 117); and 3) the remaining enzymes linked to the
lipids (n¼ 85). The numbers of nonsynonymous substitu-
tions (Dn) and synonymous substitutions (Ds) for these
enzymes were obtained from Ensembl Biomart v. 67 (Flicek
et al. 2012) (fig. 5a and b). Expression levels (RPKM) for these
enzymes were obtained from Brawand et al. (2011) (fig. 5c).
RPKM values were log2 transformed, then the quantile nor-
malization was applied, and the values were Z-transformed.
Code Accessibility
The Perl and R source code implementing the analytical
procedures described earlier is available at http://cb.
skoltech.ru/khrameeva/evolipids/code.
Supplementary Material
Supplementary data are available at Molecular Biology and
Evolution online.
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